Yellow fever as well as larvae-eating fish and copepods, which reduce the number of larvae. For many years, copepods of the genus "Mesocyclops" have been used in Vietnam for preventing dengue fever. It eradicated the mosquito vector in several areas. Similar efforts may be effective against yellow fever. Pyriproxyfen is recommended as a chemical larvicide, mainly because it is safe for humans and effective even in small doses. The second strategy is to reduce populations of the adult yellow fever mosquito. Lethal ovitraps can reduce "Aedes" populations, but with a decreased amount of pesticide because it targets the mosquitoes directly. Curtains and
Yellow fever vaccine fever certificate of vaccination for travelers. Increases in cases of yellow fever in endemic areas of Africa and South America in the 1980s were addressed by the WHO Yellow Fever Initiative launched in the mid-2000s. The initiative was supported by the Gavi Alliance, a collaboration of the WHO, UNICEF, vaccine manufacturers, and private philanthropists such as the Bill & Melinda Gates Foundation. Gavi-supported vaccination campaigns since 2011 have covered 88 million people in 14 countries considered at "high-risk" of a yellow fever outbreak (Angola was considered "medium risk"). Activities of the Yellow Fever Initiative are managed through an international coordinating